MiNK Therapeutics (INKT) SEC Filings & 10K Form

$0.93
0.00 (0.00%)
(As of 05/8/2024 ET)

Recent MiNK Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2024
4:25 PM
MiNK Therapeutics (Filer)
Form DEF 14A
03/21/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
5:00 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:05 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
5:05 PM
ARMEN GARO H (Filed by)
MiNK Therapeutics (Subject)
Form SC 13D
02/14/2024
7:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:00 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:00 PM
MiNK Therapeutics (Issuer)
van Dijk Marcus Antonius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:05 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:11 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
3:15 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:49 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
7:18 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:26 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
8:15 PM
Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:00 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:01 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:01 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:02 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:04 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2023
4:53 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
4:15 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
6:44 AM
MiNK Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2023
6:26 AM
MiNK Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
2:45 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
7:20 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:03 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:07 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:11 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
7:13 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:39 PM
Baldoni John (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:40 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:41 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:42 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk Secret Crypto Plot Exposed (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
06/02/2023
6:43 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:12 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/26/2023
4:28 PM
AGENUS INC (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/26/2023
4:29 PM
ARMEN GARO H (Reporting)
MiNK Therapeutics (Issuer)
Form 4/A
05/11/2023
7:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INKT) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners